RaDVaC Data Explorer
Antiviral database
Virus Taxonomy
← Back to Dashboard
Dovato
Integrase strand transfer inhibitor + NRTI
Constituent drugs (2)
Dolutegravir
Loading structure...
3D not available
Lamivudine
Loading structure...
3D not available
Chemical Identifiers
ClinicalTrials.gov
PubMed
Clinical Development by Virus
1
Human immunodeficiency virus 1
HIV-1
Target: Viral integrase + RT
Approved (other)
Preclinical
Phase 2
positive
Phase 3
positive
Approved
Japan
Approval ref (pmda.go.jp)
PMDA approved Jan. 14, 2020
fixed-dose combination of Dolutegravir, Lamivudine.